Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

209
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
209
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

236
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
236
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

116
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
116
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

213
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
213
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

156
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
156
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

201
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colchicine in coronary heart disease: from inflammatory biology to secondary prevention.

Clinical and experimental rheumatology·2026
Same author

Incidental cardiac mass: when the past influences the future.

European heart journal. Imaging methods and practice·2026
Same author

One echocardiographic or hemodynamic parameter improves mortality prediction by the ESC/ERS four-strata model: a flexible approach to follow-up risk stratification in pulmonary arterial hypertension.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Arrhythmic Myocarditis and Prevention of Sudden Cardiac Death: Current Evidence, Risk Stratification, and Management.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Management of pericarditis: recent advances.

Polish archives of internal medicine·2026
Same author

[Ten clinical questions about recurrent or incessant pericarditis].

Giornale italiano di cardiologia (2006)·2026

Related Experiment Video

Updated: Dec 21, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.8K

Noninfectious pericarditis: management challenges for cardiologists.

Massimo Imazio1

  • 1University Cardiology, AOU Città della Salute e della Scienza di Torino,Torino, Italy. massimo_imazio@yahoo.it

Kardiologia Polska
|May 13, 2020
PubMed
Summary

Managing noninfectious pericarditis involves diagnosing and treating its causes, often excluding tuberculosis. Key treatments include anti-inflammatory drugs and colchicine, with advanced options for resistant cases.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.0K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K

Related Experiment Videos

Last Updated: Dec 21, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.8K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.0K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Rheumatology

Background:

  • Noninfectious pericarditis presents diagnostic and therapeutic challenges.
  • Etiology varies globally, with tuberculosis being prevalent in developing countries.
  • Common causes include autoimmune diseases, post-cardiac injury, and malignancy.

Purpose of the Study:

  • To review management strategies for noninfectious pericarditis.
  • To highlight diagnostic criteria and prognostic indicators.
  • To discuss current and emerging therapeutic options.

Main Methods:

  • Review of current literature on pericarditis diagnosis and management.
  • Analysis of etiological factors based on geographical prevalence.
  • Evaluation of clinical, laboratory, and imaging diagnostic tools.
  • Assessment of treatment guidelines and novel therapies.

Main Results:

  • Diagnosis relies on clinical signs, elevated C-reactive protein, and imaging.
  • Poor prognostic factors include fever, large effusion, and poor treatment response.
  • Standard therapy involves NSAIDs and colchicine; corticosteroids and anakinra for refractory cases.
  • Recurrence is common, but constrictive pericarditis risk depends on etiology.

Conclusions:

  • Accurate diagnosis and risk stratification are crucial for effective management.
  • A stepwise therapeutic approach is recommended, from basic anti-inflammatories to targeted agents.
  • Understanding etiological factors guides treatment and predicts long-term outcomes.